Compugen (CGEN) Payables (2009 - 2026)
Compugen (CGEN) posted quarterly Payables of $2.5 million for Q1 2026, down 76.92% year-over-year from $10.9 million in Q1 2025, and up 7.35% on a QoQ basis from $2.4 million in Q4 2025.
Compugen (CGEN) Payables (2009 - 2026) Analysis & Trends
Compugen has reported Payables for 18 years, with the latest figure at $2.5 million in Q1 2026.
- Payables for Q1 2026 came in at $2.5 million, down 76.92% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.5 million (down 76.92% YoY), and the FY2025 annual result was $2.4 million, up 28.02% from the prior year.
- Payables rose to $2.5 million in Q1 2026, from $2.4 million in the prior quarter.
- Over five years, Payables peaked at $14.5 million in Q4 2023 and troughed at $1.7 million in Q2 2023.
- A 5-year average of $7.6 million and a median of $9.8 million in 2023 frame the typical range for Payables.
- The widest annual swing landed in 2022, when Payables surged 137.63%; it then tumbled 87.31% in 2024.
- A 5-year view of Payables shows it stood at $11.0 million in 2022, then jumped by 31.91% to $14.5 million in 2023, then slumped by 87.31% to $1.8 million in 2024, then climbed by 28.02% to $2.4 million in 2025, then grew by 7.35% to $2.5 million in 2026.
- Per Business Quant data, the three most recent Payables figures were $2.5 million in Q1 2026, $2.4 million in Q4 2025, and $9.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Compugen | 227.88 Mn | 136.13 Mn | 352,000.00 | 2.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.53 Mn |
| Dec 31, 2025 | 2.35 Mn |
| Sep 30, 2025 | 9.12 Mn |
| Jun 30, 2025 | 1.79 Mn |
| Mar 31, 2025 | 10.94 Mn |
| Dec 31, 2024 | 1.84 Mn |
| Sep 30, 2024 | 11.40 Mn |
| Jun 30, 2024 | 2.38 Mn |
| Mar 31, 2024 | 13.43 Mn |
| Dec 31, 2023 | 14.49 Mn |
| Sep 30, 2023 | 9.78 Mn |
| Jun 30, 2023 | 1.68 Mn |
| Mar 31, 2023 | 10.10 Mn |
| Dec 31, 2022 | 10.98 Mn |
| Sep 30, 2022 | 12.52 Mn |
| Jun 30, 2022 | 2.15 Mn |
| Mar 31, 2022 | 11.45 Mn |
| Dec 31, 2021 | 4.62 Mn |
| Sep 30, 2021 | 13.66 Mn |
| Jun 30, 2021 | 1.81 Mn |